Alison Louise Tutt

Title: Innovations in Immune Therapies by Alison Louise Tutt

Introduction

Alison Louise Tutt is a prominent inventor based in Chilworth, GB. She has made significant contributions to the field of immunology, particularly in developing therapies aimed at enhancing the immune response against various diseases, including cancer.

Latest Patents

Alison Louise Tutt holds 3 patents that focus on human immune therapies utilizing a CD27 agonist. Her latest patents include methods for inducing T cell proliferation and expansion in vivo, which are crucial for treating conditions where antigen-specific T cell immune responses are therapeutically desirable. These methods involve administering at least one CD27 agonist, preferably an agonistic CD27 antibody, either alone or in combination with other immune stimulants or modulators. The therapies may also include the administration of desired antigens, such as tumor antigens or allergens, to elicit a robust T cell response.

Career Highlights

Alison is affiliated with the University of Southampton, where she continues her research and development in immune therapies. Her work has been instrumental in advancing the understanding of immune modulation and its applications in treating various health conditions.

Collaborations

Some of her notable coworkers include Martin John Glennie and Aymen Al-Shamkhani, who have collaborated with her on various research projects aimed at improving immune therapies.

Conclusion

Alison Louise Tutt's innovative work in immune therapies showcases her dedication to advancing medical science and improving treatment options for patients. Her contributions are paving the way for new therapeutic strategies in immunology.